These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38275584)

  • 1. DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort.
    Aiello V; Ciurli F; Conti A; Cristalli CP; Lerario S; Montanari F; Sciascia N; Vischini G; Fabbrizio B; Di Costanzo R; Olivucci G; Pietra A; Lopez A; Zambianchi L; La Manna G; Capelli I
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
    Cornec-Le Gall E; Olson RJ; Besse W; Heyer CM; Gainullin VG; Smith JM; Audrézet MP; Hopp K; Porath B; Shi B; Baheti S; Senum SR; Arroyo J; Madsen CD; Férec C; Joly D; Jouret F; Fikri-Benbrahim O; Charasse C; Coulibaly JM; Yu AS; Khalili K; Pei Y; Somlo S; Le Meur Y; Torres VE; ; ; ; Harris PC
    Am J Hum Genet; 2018 May; 102(5):832-844. PubMed ID: 29706351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta.
    Ciantar N; Zahra G; Delicata J; Sammut F; Calleja-Agius J; Farrugia E; Said E
    Eur J Med Genet; 2024 Jun; 69():104934. PubMed ID: 38537868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
    Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T
    JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
    Ghosh Roy S; Li Z; Guo Z; Long KT; Rehrl S; Tian X; Dong K; Besse W
    J Am Soc Nephrol; 2023 Sep; 34(9):1521-1534. PubMed ID: 37332102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical ADPKD Due to a
    Kachmar J; El-Haffaf Z; Bollée G
    Can J Kidney Health Dis; 2023; 10():20543581231203054. PubMed ID: 37867501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease.
    Huynh VT; Audrézet MP; Sayer JA; Ong AC; Lefevre S; Le Brun V; Després A; Senum SR; Chebib FT; Barroso-Gil M; Patel C; Mallett AJ; Goel H; Mallawaarachchi AC; Van Eerde AM; Ponlot E; Kribs M; ; Le Meur Y; Harris PC; Cornec-Le Gall E
    Kidney Int; 2020 Aug; 98(2):476-487. PubMed ID: 32631624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
    Lemoine H; Raud L; Foulquier F; Sayer JA; Lambert B; Olinger E; Lefèvre S; Knebelmann B; Harris PC; Trouvé P; Desprès A; Duneau G; Matignon M; Poyet A; Jourde-Chiche N; Guerrot D; Lemoine S; Seret G; Barroso-Gil M; Bingham C; Gilbert R; ; ; Le Meur Y; Audrézet MP; Cornec-Le Gall E
    Am J Hum Genet; 2022 Aug; 109(8):1484-1499. PubMed ID: 35896117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing of Saudi Arabian patients with ADPKD.
    Al-Muhanna FA; Al-Rubaish AM; Vatte C; Mohiuddin SS; Cyrus C; Ahmad A; Shakil Akhtar M; Albezra MA; Alali RA; Almuhanna AF; Huang K; Wang L; Al-Kuwaiti F; Elsalamouni TSA; Al Hwiesh A; Huang X; Keating B; Li J; Lanktree MB; Al-Ali AK
    Ren Fail; 2019 Nov; 41(1):842-849. PubMed ID: 31488014
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
    Raj S; Singh RG; Das P
    Mutat Res; 2020; 821():111718. PubMed ID: 32823016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
    Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
    Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
    Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel mutations and risk assessment of Han Chinese patients with autosomal dominant polycystic kidney disease.
    Zhang M; Liu S; Xia X; Cui Y; Li X
    Nephrology (Carlton); 2019 May; 24(5):504-510. PubMed ID: 29633482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
    Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
    Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More dissimilarities than affinities between DNAJB11-PKD and ADPKD.
    Pisani I; Allinovi M; Palazzo V; Zanelli P; Gentile M; Farina MT; Giuliotti S; Cravedi P; Delsante M; Maggiore U; Fiaccadori E; Manenti L
    Clin Kidney J; 2022 Jun; 15(6):1179-1187. PubMed ID: 35664268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Next Generation Sequencing Revealed Novel Variants in the
    Hosseinpour M; Ardalani F; Mohseni M; Beheshtian M; Arzhangi S; Ossareh S; Najmabadi H; Nobakht A; Kahrizi K; Broumand B
    Arch Iran Med; 2022 Sep; 25(9):600-608. PubMed ID: 37543885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing.
    Mallawaarachchi AC; Lundie B; Hort Y; Schonrock N; Senum SR; Gayevskiy V; Minoche AE; Hollway G; Ohnesorg T; Hinchcliffe M; Patel C; Tchan M; Mallett A; Dinger ME; Rangan G; Cowley MJ; Harris PC; Burnett L; Shine J; Furlong TJ
    Eur J Hum Genet; 2021 May; 29(5):760-770. PubMed ID: 33437033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoallelic pathogenic
    Dordoni C; Zeni L; Toso D; Mazza C; Mescia F; Cortinovis R; Econimo L; Savoldi G; Alberici F; Scolari F; Izzi C
    Clin Kidney J; 2024 Feb; 17(2):sfae026. PubMed ID: 38404363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease.
    Kurashige M; Hanaoka K; Imamura M; Udagawa T; Kawaguchi Y; Hasegawa T; Hosoya T; Yokoo T; Maeda S
    Clin Genet; 2015 Mar; 87(3):266-72. PubMed ID: 24611717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.